Why the study?
Do antiplatelet agents decrease the risk of vascular events?
Design
Review
Authors
Loading...
Supports antiplatelet use for vascular prevention; leaves open validation of reliable platelet activity markers for risk stratification.
Do antiplatelet agents decrease the risk of vascular events?
This review highlights the efficacy of antiplatelet agents in preventing vascular events while noting the critical need for reliable markers of platelet activity to identify high-risk patients.
Jagroop et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: